R James Barnard
Overview
Explore the profile of R James Barnard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
1919
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hall J, Dixson G, Barnard R, Pritikin N
Phys Sportsmed
. 2017 Dec;
10(5):90-101.
PMID: 29278187
In brief A 46-year-old man presented with symptoms of peripheral vascular disease in 1966. In 1976 arteriography revealed 100% occlusion of both femoral arteries at midthigh and some reconstitution of...
2.
Franklin B, Durstine J, Roberts C, Barnard R
Best Pract Res Clin Endocrinol Metab
. 2014 May;
28(3):405-21.
PMID: 24840267
Unfortunately, many patients as well as the medical community, continue to rely on coronary revascularization procedures and cardioprotective medications as a first-line strategy to stabilize or favorably modify established risk...
3.
Roberts C, Izadpanah A, Angadi S, Barnard R
Am J Physiol Regul Integr Comp Physiol
. 2013 Jul;
305(5):R552-7.
PMID: 23883675
Lifestyle intervention programs currently emphasize weight loss secondary to obesity as the primary determinant of phenotypic changes. We examined whether the effects of a short-term lifestyle intervention program differ in...
4.
Roberts C, Hevener A, Barnard R
Compr Physiol
. 2013 May;
3(1):1-58.
PMID: 23720280
Metabolic syndrome (MS) is a collection of cardiometabolic risk factors that includes obesity, insulin resistance, hypertension, and dyslipidemia. Although there has been significant debate regarding the criteria and concept of...
5.
Izadpanah A, Barnard R, Almeda A, Baldwin G, Bridges S, Shellman E, et al.
Am J Physiol Endocrinol Metab
. 2012 Jun;
303(4):E542-50.
PMID: 22713506
The present study was designed to examine the effects of short-term diet and exercise on markers of metabolic health, serum-stimulated production of inflammatory biomarkers from cultured monocytes and adipocytes, and...
6.
Konijeti R, Koyama S, Gray A, Barnard R, Said J, Castor B, et al.
Mol Cancer Ther
. 2012 May;
11(7):1539-46.
PMID: 22562985
In preclinical models, both dietary fat reduction and insulin-like growth factor I receptor (IGF-1R) blockade individually inhibit prostate cancer xenograft growth. We hypothesized that a low-fat diet combined with IGF-1R...
7.
Aronson W, Kobayashi N, Barnard R, Henning S, Huang M, Jardack P, et al.
Cancer Prev Res (Phila)
. 2011 Oct;
4(12):2062-71.
PMID: 22027686
Preclinical studies suggest lowering dietary fat and decreasing the ratio of omega-6 to omega-3 polyunsaturated fatty acids decreases the risk of prostate cancer development and progression. We conducted a phase...
8.
Global Igfbp1 deletion does not affect prostate cancer development in a c-Myc transgenic mouse model
Gray A, Aronson W, Barnard R, Mehta H, Wan J, Said J, et al.
J Endocrinol
. 2011 Sep;
211(3):297-304.
PMID: 21903863
Circulating insulin-like growth factor binding protein 1 (IGFBP1) levels vary in response to nutritional status, and pre-clinical studies suggest that elevated IGFBP1 may be protective against the development and progression...
9.
Barnard R, Aronson W
Phys Sportsmed
. 2010 Jan;
37(4):141-6.
PMID: 20048551
Benign prostatic hyperplasia (BPH) is a very common condition in older men, affecting up to 80% of men aged >or= 80 years in the United States. It typically leads to...
10.
Aronson W, Barnard R, Freedland S, Henning S, Elashoff D, Jardack P, et al.
J Urol
. 2009 Nov;
183(1):345-50.
PMID: 19914662
Purpose: A high fat Western diet and sedentary lifestyle may predispose men to prostate cancer through changes in serum hormones and growth factors. We evaluated the effect of a low...